Methyl Aminolevulinate Hydrochloride

CHEMBL1201093 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
181.6 g/mol
LogP
Phase
4

A hydrochloride form of methyl aminolevulinate with the same therapeutic properties. A photosensitizer for photodynamic therapy of actinic keratoses.

Moleküler Ağırlık

181,6200 g/mol

TPSA

69,40 Ų

Terapötik Alanlar

Etki Mekanizması

Accumulates in target tissues and generates reactive oxygen species upon activation by specific wavelengths of light, causing localized cellular damage and destruction of pathological tissue.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanizma

Accumulates in target tissues and generates reactive oxygen species upon activation by specific wavelengths of light, causing localized cellular damage and destruction of pathological tissue.

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COC(=O)CCC(=O)CN.Cl

InChI

InChI=1S/C6H11NO3.ClH/c1-10-6(9)3-2-5(8)4-7;/h2-4,7H2,1H3;1H

Molecular Formula

C6H12ClNO3

HBD / HBA

2 / 4

Döndürülebilir Bağlar

5

Ağır Atomlar

11

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A hydrochloride form of methyl aminolevulinate with the same therapeutic properties. A photosensitizer for photodynamic therapy of actinic keratoses.

Accumulates in target tissues and generates reactive oxygen species upon activation by specific wavelengths of light, causing localized cellular damage and destruction of pathological tissue.

Yes, Methyl Aminolevulinate Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201093. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 157921. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.